Society guideline links: Acne vulgaris

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Canada

●Choosing Wisely Canada: Don't order unnecessary blood tests (ie, complete blood counts and basic metabolic panels) for the routine monitoring of isotretinoin in otherwise healthy individuals treated for acne (2023)

●Choosing Wisely Canada: Don't use oral antibiotics for acne vulgaris for more than 3 months without assessing efficacy (2023)

●Management of acne – Canadian clinical practice guideline (2016)

United States

●American Academy of Dermatology (AAD): Guidelines of care for the management of acne vulgaris (2016)

●American Acne and Rosacea Society (AARS): Evidence-based recommendations for the diagnosis and treatment of pediatric acne (2013)

Europe

●European Dermatology Forum (EDF): European evidence-based (S3) guideline for the treatment of acne, update (2016)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on acne vulgaris – Management (2021, updated 2023)

Australia–New Zealand

●Choosing Wisely Australia: Monotherapy for acne with either topical or systemic antibiotics should be avoided (reviewed 2021)

Japan

●[In Japanese] Japanese Dermatological Association (JDA): Acne vulgaris and rosacea treatment guidelines (2023)